Login / Signup

Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme.

Kavitha GoduguBruce A HayGennadi V GlinskyShaker A Mousa
Published in: Neuro-oncology advances (2022)
fb-PMT is a potent thyrointegrin αvβ3 antagonist with potential impact on GBM tumor progression.
Keyphrases
  • endothelial cells
  • small molecule
  • poor prognosis
  • induced pluripotent stem cells
  • pluripotent stem cells
  • high throughput